Effects of Changing From Typical to Atypical Antipsychotic Drugs on Subjective Sleep Quality in Patients With Schizophrenia in a Japanese Population
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To investigate the effects of the atypical antipsychotic drugs risperidone, olanzapine, quetiapine, and perospirone on the subjective quality of sleep in patients with schizophrenia. METHOD: Subjects were 92 inpatients (mean age = 59.9 years) who had been receiving treatment with conventional antipsychotic drugs and who met the DSM-IV criteria for schizophrenia. Subjects were randomly assigned to receive 1 of 4 atypical antipsychotic drugs (olanzapine, perospirone, quetiapine, and risperidone). Subjective sleep quality and psychopathology were assessed twice: at baseline and 8 weeks after switching. Data were collected from June 2001 to December 2001. Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI), and psychopathology was measured by the Positive and Negative Syndrome Scale (PANSS). RESULTS: Subjective sleep quality as assessed by the PSQI was significantly improved with administration of olanzapine, risperidone, or quetiapine, but not with perospirone, in comparison with conventional antipsychotic drugs. Multiple regression analysis revealed that the improvement of sleep quality with administration of atypical antipsychotic drugs was predicted by poor sleep quality at baseline. In addition, improvement of sleep quality was significantly correlated with improvement of negative symptoms as assessed by the PANSS. CONCLUSION: These results demonstrated that atypical antipsychotic drugs improved subjective quality of sleep in patients with schizophrenia compared with conventional antipsychotic drugs, suggesting that the marked potency of serotonin-2 receptor blockade in atypical antipsychotic drugs may be involved in the mechanism of this improvement. These improvements were correlated with improvement of negative symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of studies indicate that improvement in symptoms following antipsychotic treatment is associated with improvement in sleep variables (Taylor et al., 1991a, Yamashita et al., 2004, Yamashita et al., 2005).”
From The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review (2015) · cites this paper as Yamashita et al., 2004
Citations
Cites
Still being checked.
Cited by
Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics
Cohrs, S. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00004 · Cited by 433
The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review
Reeve, S., Sheaves, B., & Freeman, D. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.09.001 · Cited by 273
“Y Yamashita et al. (2004) 92 Inpatients with schizophrenia — same sample as (Yamashita et al., 2005), average age 61.5 Observed over change from conventional to atypical antipsychotics Positive symptoms PANSS (baseline and 8 weeks post change completion) Subjective sleep PSQI (baseline and 8 weeks…”
BackgroundInfluentialQuality of sleep in patients with schizophrenia is associated with quality of life and coping
Hofstetter, J. R., Lysaker, P. H., & Mayeda, A. R. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-13 · Cited by 155
Sleep in Schizophrenia: Impairments, Correlates, and Treatment
Benson, K. L. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.08.002 · Cited by 125
Evaluating the links between schizophrenia and sleep and circadian rhythm disruption
Pritchett, D., Wulff, K., Oliver, P. L., Bannerman, D. M., Davies, K. E., Harrison, P. J., Peirson, S. N., & Foster, R. G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0817-8 · Cited by 107
Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling
Ashton, A., & Jagannath, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00636 · Cited by 106
“sleep stabilization includes traditional sedative-hypnotics such as benzodiazepines, and second generation sedating antipsychotics such as quetiapine, olanzapine and risperidone improve sleep quality, and pharmacotherapy for sleep also correlates with an improvement in negative symptoms (Kajimura et al., 1995; Yamashi…”
BackgroundRisperidone versus olanzapine for schizophrenia
Jayaram, M., Hosalli, P., & Stroup, T. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005237.pub2 · Cited by 97
Neurotransmitter Targeting in the Treatment of Depression
Blier, P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12084su1c.04 · Cited by 84
Kantrowitz, J., Citrome, L., & Javitt, D. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00005 · Cited by 72
Zanini, M., Castro, J., Coelho, F. M., Bittencourt, L., Bressan, R. A., Tufik, S., & Brietzke, E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.012 · Cited by 69
Effects of Quetiapine on Sleep in Nonpsychiatric and Psychiatric Conditions
Wine, J. N., Sanda, C., & Caballero, J. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l320 · Cited by 56
Dream content in chronically-treated persons with schizophrenia
Lusignan, F., Zadra, A. L., Dubuc, M.-J., Daoust, A.-M., Mottard, J., & Godbout, R. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.032 · Cited by 63
Schizophrenia: the role of sleep and circadian rhythms in regulating dopamine and psychosis
Yates, N. J. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0030 · Cited by 62
Edwards, S. J., & Smith, C. J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.004 · Cited by 46
Clinical Pharmacology of Other Drugs Used as Hypnotics
Buysse, D. J., & Tyagi, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00042-8 · Cited by 37
Suh, G., Greenspan, A. J., & Choi, S. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1693 · Cited by 33
Suh, G., Greenspan, A. J., & Choi, S. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1542 · Cited by 40
Management of Schizophrenia in Late Life with Antipsychotic Medications: A Qualitative Review
Suzuki, T., Remington, G. J., Uchida, H., Rajji, T. K., Graff‐Guerrero, A., & Mamo, D. C. (2011) · Drugs & Aging · doi:10.2165/11595830-000000000-00000 · Cited by 37
Yamashita, H., Mori, K., Nagao, M., Okamoto, Y., Morinobu, S., & Yamawaki, S. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200505000-00006 · Cited by 30
Self-citationPharmacologic Treatment Options for Insomnia in Patients with Schizophrenia
Stummer, L., Marković, M., & Maroney, M. E. (2018) · Medicines · doi:10.3390/medicines5030088 · Cited by 34
Kishi, T., Ikuta, T., Sakuma, K., Okuya, M., & Iwata, N. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.04.032 · Cited by 27
Kishi, T., Ikuta, T., Matsunaga, S., Matsuda, Y., Oya, K., & Iwata, N. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s134340 · Cited by 30
Kishi, T., Matsuda, Y., & Iwata, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088049 · Cited by 25
Mehta, R., Giri, S., & Mallick, B. N. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00222-1 · Cited by 25
Sedation in Critically Ill Patients
Oldham, C. M., & Pisani, M. A. (2015) · Critical Care Clinics · doi:10.1016/j.ccc.2015.03.010 · Cited by 25
Khazaie, H., Rezaie, L., Darvishi, F., Najafi, F., & Avis, K. T. (2013) · Neurosciences · doi:10.17712/1658-3183.1994 · Cited by 21
Kishi, T., & Iwata, N. (2013) · CNS Drugs · doi:10.1007/s40263-013-0085-7 · Cited by 23
Insomnia treatment by Olanzapine. Is sleep state misperception a psychotic disorder?
Khazaie, H., Rezaie, L., Tahmasian, M., & Schwebel, D. C. (2010) · Neurosciences · doi:10.17712/1658-3183.1778 · Cited by 15
Drug Class Review: Atypical Antipsychotic Drugs
McDonagh, M. S., Peterson, K., Carson, S., Fu, R., & Thakurta, S. (2010) · Cited by 16
An Algorithmic Approach to the management of Insomnia in Patients with Schizophrenia
Cole, K., Tabbane, K., Boivin, D. B., & Joober, R. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900207 · Cited by 15
Alcohol, toxins, and medications as a cause of sleep dysfunction
Conroy, D. A., & Brower, K. J. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00038-1 · Cited by 14
The effect of typical and atypical antipsychotic drugs on sleep of schizophrenic patients
Winokur, A., & Kamath, J. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_24 · Cited by 15
Clinical Pharmacology of Other Drugs Used as Hypnotics
Buysse, D. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00043-8 · Cited by 12
Sato, G., Yoshimura, S., Yamashita, H., Okamoto, Y., & Yamawaki, S. (2012) · PubMed · Cited by 6
de Crom, S. A. M., de Haan, L., & Schirmbeck, F. N. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113728 · Cited by 4
Nakanishi, S., Kunugi, H., Murray, R. M., Nojima, S., Ogawa, T., & TAKAHASHI, T. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01591.x · Cited by 4
Sumaya, I. C., & Dubocovich, M. L. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113827 · Cited by 2
Samara, M. T., Kottmaier, E., Helfer, B., Leucht, C., Christodoulou, G. N., Huhn, M., Rothe, P., Schneider‐Thoma, J., & Leucht, S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011885.pub2 · Cited by 8
Hussain, S., Villarreal, S., Ramirez, N., Hussain, A., & Sumaya, I. C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112313 · Cited by 2
Schizofreniespectrum- en andere psychotische stoornissen
van Deth, R. (2017) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1045-6_2
Basic mechanisms of, and possible treatment targets for, sleep–wake disorders
Pritchett, D., Fisk, A. S., Foster, F., & Peirson, S. N. (2020) · doi:10.1093/med/9780198713005.003.0109
Current awareness in human psychopharmacology
(2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.635
Schizofreniespectrum- en andere psychotische stoornissen
Peters, A., Brakema, L., van de Hoeve, M., Spoelstra, K., & Knegtering, H. (2020) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2524-5_10
Effects of add-on asenapine therapy on sleep in schizophrenia: a case series
Otsuki, R., Kojima, Y., Fujii, N., Kizuki, J., Kanamori, T., Kaneko, Y., & Suzuki, M. (2026) · Sleep and Biological Rhythms · doi:10.1007/s41105-026-00635-x
D’Ambrosio, S., Cavallotti, S., del Giudice, R., Dibenedetto, C., & D’Agostino, A. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2718395
Sleep disturbances as an early indicator of psychotic disorders in adolescents and young adults
Jaromirska, J., Strzelecki, D., Kotlicka‐Antczak, M., Białasiewicz, P., & Gabryelska, A. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1949833
Metadata
- Authors
- Yamashita, H., Mori, K., Nagao, M., Okamoto, Y., Morinobu, S., & Yamawaki, S.
- Affiliations
- Hiroshima University (JP)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-11-15
- Volume
- 65
- Issue
- 11
- Pages
- 1525-1530
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1987549938
- Cited by
- 46
- References
- 0
- Citations by year
- 2026: 3 · 2025: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- atypical antipsychotics, schizophrenia, subjective sleep quality, risperidone, olanzapine, quetiapine, perospirone, typical antipsychotics, negative symptoms, antipsychotic switching, psychopathology
- MeSH terms
- Quetiapine Fumarate, Olanzapine, Adult, Aged, Benzodiazepines, Dibenzothiazepines, Drug Administration Schedule, Female, Health Status, Hospitalization, Humans, Indoles, Japan, Male, Middle Aged, Psychiatric Status Rating Scales, Regression Analysis, Schizophrenia, Schizophrenic Psychology, Severity of Illness Index, Sleep, Thiazoles, Antipsychotic Agents, Risperidone, Isoindoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.